Company obtains access to IG’s genomic sequence for design and development.

Oxford Gene Technology (OGT) and Integrated Genomics (IG) signed a collaboration to develop and market a Pichia pastoris Gene Expression (GE) oligonucleotide microarray.

OGT thus gains access to IG’s Pichia pastoris genomic sequence for the design and development of an optimized 60-mer oligonucleotide microarray using the ink jet in situ synthesis platform. OGT will market the array worldwide, and offer a sample analysis service at its Oxford laboratory.

Previous articleMemory Pharmaceuticals’ MEM 1003 Fails in Bipolar Mania Trial
Next articleIdera Extends Asthma and Allergy Collaboration with Novartis